Skip to content
FY'25FY'24FY'23FY'22
Profitability
Operating margin33.3%+6.8pp26.5%+249pp-222%-283pp61%+4.8pp
Net margin8.1%+7.9pp0.3%+227pp-226.4%-269pp42.6%-85.1pp
EBITDA margin33.9%+7.1pp26.8%+249pp-221.8%-283pp61.3%+4.8pp
Returns
Return on assets6.4%+6.2pp0.2%+128pp-127.5%-143pp15.7%-47.0pp
Efficiency
Asset turnover0.8×-0.1×0.9×+0.3×0.6×+0.2×0.4×-0.1×
Liquidity
Current ratio1.1×-3.6×4.7×+3.8×0.8×-29.7×30.6×+26.0×
Quick ratio1.1×-3.6×4.7×+3.8×0.8×-29.7×30.6×+26.0×
Cash ratio0.9×-1.4×2.3×+1.9×0.3×-25.4×25.7×+21.9×
Leverage
Debt-to-assets0.5×+0.5×-0.4×0.5×+0.4×-0.1×
Net debt / EBITDA-0×+0.7×-0.8×-2.5×-0.5×
Interest coverage+0.2×2.8×+48.3×-45.4×-78.4×32.9×+25.5×
Per Share
Book value per share-$1.61+14.7%-$1.88+15.5%-$2.23-164%$3.50-5.0%
Valuation
Market capitalization$632.12M+457%$708.93M-60.3%$1.78B-6.1%$1.9B-11.6%
Enterprise value$624M+3,024%$635.86M-66.7%$1.91B+51.2%$1.26B-24.2%
Price / earnings6.2×805.6×10.9×+6.8×
Price / sales1.8×+1.4×-2.0×-0.6×4.6×-0.6×
EV / EBITDA3.1×+2.7×6.7×-2.1×
EV / sales1.7×+1.7×1.8×-2.5×4.3×+1.2×3.1×-1.0×
Earnings yield16.2%+44.7pp0.1%+56.3pp-56.2%-65.4pp9.2%-15.4pp
PEG ratio

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ironwood Pharmaceuticals's profit margins?
Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 55.4% operating margin, with a 28.3% net margin.
Where do Ironwood Pharmaceuticals's ratios come from?
Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.